+9.1%
GSK vs HTZ
-76.0%
+85.1%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HTZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.1% | -6.1% | +6.2% | +0.3% |
| 7D | +0.5% | -14.0% | +14.4% | +1.0% |
| 30D | +9.4% | -19.8% | +29.2% | +10.3% |
| 3M | +1.6% | -45.0% | +46.6% | +3.6% |
| 6M | +1.3% | -73.2% | +74.5% | +6.9% |
| YTD | +6.0% | -70.0% | +76.0% | +10.5% |
| 1Y | +9.1% | -75.7% | +84.8% | +16.1% |
| All | +9.1% | -76.0% | +85.1% | +16.1% |
Cumulative growth
Daily Returns
Daily percentage return beside HTZ.
Daily Out/Under-Performance
Portfolio return minus HTZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HTZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HTZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling